TXG   $15.44  3.90% Market Closed After Close 15.44 0.0

10X Genomics Inc
Total Cash 380.09M
totalCashPerShare 3.155
EBITDA -146.28M
Total Debt 89.48M
quickRatio 4.245
currentRatio 5.217
Total Revenue 631.73M
debtToEquity 12.358
Revenue/Share 5.317
ROA -0.11953
ROE -0.31605
grossProfits
freeCashflow 62.79M
operatingCashflow -7.78M
earningsGrowth
revenueGrowth 0.043
grossMargins 0.64702004
ebitdaMargins -0.23156
operatingMargins -0.27261
profitMargins -0.37957
enterpriseValue 1.63B
forwardPE -15.6
floatShares 104.40M
sharesOutstanding 106.44M
sharesShort 7.44M
sharesShortPriorMonth 8.94M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.98%
Short Ratio help_outline 5.57%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 6.01
Price To Book help_outline 2.60
earningsQuarterlyGrowth
netIncomeToCommon -239.78M
trailingEps -2.03%
forwardEps -1.00%
enterpriseToEbitda -11.12
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.34 3Q 2024
institutionsCount 362
lastUpdated Oct. 16, 2024, 8:16 p.m.